FSHD Global Research Foundation is currently seeking researchers with a serious interest in translating high-quality scientific discoveries into trial therapeutics. If you fit this category, please contact FSHD Global or alternatively, forward this information to research groups and/or contacts who you think may be interested.
FSHD Global Research Foundation has established a track-record for funding cutting edge research into Fascioscapulo Humeral Dystrophy in research institutions across the world. We currently have seven diverse projects receiving funding in five countries including the United States, Europe and Australia.
For 2010, the Foundation has targeted its research focus specifically at funding translational research. As part of this strategy, the Foundation is now calling for applications for a Phase 1b Clinical Trial with provision for up to US$400,000 in matching funding.
We are encouraging researchers with a serious interest in translating high-quality scientific discoveries into trial therapeutics to contact FSHD Global Research Foundation. If you are interested in finding out more or wish to apply for a grant, please contact the Foundation at research@fshdglobal.org or on Ph: +61 2 8007 7037.
| News Headlines |
| 19 August 2010 "Discovery opens door to therapeutic development for FSH muscular dystrophy" - National Institute of Health >more |
| 19 August 2010 "A Unifying Genetic Model for Facioscapulohumeral Muscular Dystrophy" - Science >more |
| 19 August 2010 "Reanimated 'Junk' DNA is found to cause disease" - The New York Times >more |
| |